• Text size      
  • Send this article to a friend
  • Print this article

New hope for lung cancer sufferers

A personalised lung cancer pill launched today offers new hope to people suffering from of a rare form of the disease.

The drug, Crizotinib, targets a protein found in around five in 100 sufferers – most of whom are younger than average. It is being trialled by a team at London's Royal Free Hospital.

Contextual targeting label: 

Commenting & Moderation

We moderate all comments on HeraldScotland on either a pre-moderated or post-moderated basis.
If you're a relatively new user then your comments will be reviewed before publication and if we know you well and trust you then your comments will be subject to moderation only if other users or the moderators believe you've broken the rules

Moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours. Please be patient if your posts are not approved instantly.